How Healthy Is Your Heart?

If you have signs of coronary artery disease, the HeartFlow® Analysis can help provide answers.

In order to receive a HeartFlow Analysis you must be exhibiting symptoms of coronary artery disease and must be referred by a physician. If your physician determines that testing is needed, you will first receive a standard cardiac CT scan. If disease is identified and additional information needed, your physician may then order a HeartFlow Analysis. No additional hospital visits are needed for this test, and your physician can then share the results of the test with you. Please discuss if the HeartFlow Analysis is right for you with your physician, however our customer support team can help and provide you with information to share with your care team.

CAD and Symptoms

Coronary Artery Disease (CAD) is the most common type of heart disease, affecting nearly half the adult population.

CAD develops when the coronary arteries become narrowed or blocked and cannot deliver enough oxygen-rich blood to the heart. This is usually caused by atherosclerosis, the buildup of plaque in the arteries that supply blood flow to the heart. Atherosclerosis can cause chest pains or other symptoms and increase the risk of heart attack.

The symptoms of CAD may vary in frequency and in how they present between individuals. Symptoms can happen separately or simultaneously and not all symptoms may be present. The following symptoms are the most common:

Chest pain or uncomfortable pressure

Angina is the medical term for pain, pressure or tightness you may feel in the middle or left side of your chest. Sometimes, it may feel like indigestion or heartburn. Symptoms typically last a few minutes and are relieved by rest or medication. It can accompany physical or emotional stress and may be an indication of CAD.

Pain or discomfort in one or both arms

In addition to chest pain or pressure, you may feel pain in your arms, back, shoulder, neck or jaw. In women, pain in these areas is often short-lived and sharp.

Shortness of breath

If you experience difficulty breathing or unusual fatigue with exertion, that may also mean your heart is not receiving enough blood through the coronary arteries.

Lightheadedness, nausea or a cold sweat

Breaking out in a cold sweat for no apparent reason can be a symptom of CAD. Excessive sweating may be accompanied by dizziness, light-headedness, extreme weakness or nausea.

The good news is that CAD is treatable in ways that can both relieve symptoms and lower the risk of a heart attack. Getting the correct diagnosis for your symptoms is crucial in determining the appropriate treatment.

The Way CAD is Diagnosed Today

Utilizes electrocardiography to track the heart’s electrical activity while a
patient exercises – typically on a treadmill – and to understand whether the heart
may have inadequate blood supply under stress.
+ No radiation exposure
+ Readily accessible
Less accurate compared to other CAD tests1
Often leads to additional testing
 
Uses nuclear imaging to compare blood flow at rest and under exercise or medication-induced stress.
+ Accessible and well known
Low sensitivity leading to a high rate of disease that goes undetected (false negative results)2
Does not provide specific information about blockages in the heart’s arteries
High radiation exposure3
 
Uses sound waves to take ultrasound images of the heart to compare performance at rest with performance under exercise or medication-induced stress.
+ No radiation exposure
Does not provide information about blockages in the heart’s arteries
A CT scan uses X-rays to view the heart and blood vessels to identify narrowings that could cause blood flow restrictions.
+ Provides very detailed images, making it easier to identify visible blockages in the blood vessels
+ Low radiation exposure and better long-term outcomes than stress tests3.4
Does not provide information on whether blood flow is actually impaired by narrowings in the heart’s arteries
This invasive test takes X-rays of the heart’s arteries while a catheter is inserted into the groin or wrist and threaded up to the heart to detect narrowed or blocked coronary arteries.
+ High accuracy in ruling out CAD
High radiation exposure5
Invasive test, exposing risk to the patient
Often unnecessary – 55% of patients who undergo an ICA do not have obstructive CAD1

The HeartFlow Difference

Now there is a non-invasive way of diagnosing CAD with more accuracy: the HeartFlow Analysis.7 This cardiac test provides a personalized, color-coded 3D model of your coronary arteries showing how the blockages are impacting blood. The HeartFlow Analysis is the first and only non-invasive test which enables your physician to understand the impact that narrowings and blockages have on blood flow to your heart – information that otherwise would only be available with a riskier, invasive procedure.

  • Enables a more accurate diagnosis of CAD compared to other non-invasive tests7
  • Provides <1% chance of missing disease8
  • Non-invasive, therefore imposing less risk
  • Provides a streamlined experience with fewer unnecessary tests and outpatient visits6
  • No additional radiation exposure

How it Works

Your doctor will order a standard CT scan of your heart to look for CAD. If the scan shows narrowings in your coronary arteries, your doctor may order a HeartFlow Analysis.

Your doctor receives your HeartFlow Analysis – a personalized, color-coded 3D model of your coronary arteries showing how the blockages are impacting blood flow. This gives your doctor the detailed information needed to better understand the severity of disease.

After interpreting your HeartFlow Analysis, your doctor will follow up with you to discuss the optimal next steps in your treatment plan.

Patient Stories

Find Out if the HeartFlow Analysis is Right for You

Speak to our HeartFlow representative or request a digital information kit to share with your doctor.

Find HeartFlow Near You

Patient Billing

The HeartFlow Analysis is a personalized cardiac test indicated for use in clinically stable symptomatic patients with coronary artery disease. The information provided by the HeartFlow Analysis is intended to be used in conjunction with the patient’s clinical history, symptoms and other diagnostic tests, as well as the clinician’s professional judgment. Patient symptoms must be documented in the patient’s medical record. While no diagnostic test is perfect, the HeartFlow Analysis has demonstrated higher diagnostic performance compared to other non-invasive cardiac tests.7 If you are a patient and suspect this test may be right for you, please speak with your doctor.

  1. Patel, et al. N Engl J Med 2010. Patel, et al. AHJ 2014.
  2. Melikian, et al. JACC: Cardiovasc Interv 2010; Jung, et al. Euro Heart J 2008. Koo, et al. J Am Coll; Cardiol 2011. Min, et al. JAMA 2012. Nørgaard, et al. J Am Coll Cardiol 2014.
  3. Stocker, et al. Euro Heart J 2018.
  4. Newby, et al. N Engl Med 2018.
  5. Partridge, J., Radiation in the cardiac catheter laboratory. Heart., 2005. 91(12): p. 1615-1620.
  6. Douglas, et al. J Am Coll Cardiol 2016.
  7. Driessen, et al. J Am Coll Cardiol 2019; Norgaard, et al, Euro J Radiol 2015.
  8. Hecht, H., et al., Should NICE guidelines be universally accepted for the evaluation of stable coronary disease? A debate. Euro Heart J 2019. DOI: 10.1093/eurheartj/ehz024.

Contact Us

*Required fields

Request the HeartFlow Analysis Near You

If you would like to request to have the HeartFlow Analysis available at a location near you, please submit your information below with details of the institution. We will share this information with the institution, but it will not guarantee HeartFlow will become available.

*Required fields

残念ながら、GDPR 規制により、この Web フォームを通じて求人への応募やキャリアに関する問い合わせを受け付けることはできません。弊社を通じてお申込みください 採用ページ. ご関心をお寄せいただきありがとうございます!

オンライン提出フォームから研究助成金を申請してください。

HeartFlow FFRCT 分析は、有資格の臨床医による臨床的に安定した症状のある冠状動脈疾患患者への使用を目的とした個別化された心臓検査です。 HeartFlow Analysis によって提供される情報は、資格のある臨床医が患者の病歴、症状、その他の診断検査、および臨床医の専門的判断と組み合わせて使用​​することを目的としています。

ハートフロー分析に関する追加の適応情報については、次のサイトをご覧ください。www.heartflow.com/indications.

さらに質問がある場合は、このメッセージを閉じてフォームに記入するか、サポート チームにお電話ください。: 877.478.3569.

The HeartFlow FFRCT Analysis is a personalized cardiac test indicated for use in clinically stable symptomatic patients with coronary artery disease by qualified clinicians. The information provided by the HeartFlow Analysis is intended to be used by qualified clinicians in conjunction with the patient’s history, symptoms, and other diagnostic tests, as well as the clinician’s professional judgement.

For additional indication information about the HeartFlow Analysis, please visit www.heartflow.com/indications.

If you have additional questions, close out of this message to complete our form or call our support team: 877.478.3569.

Please use our online submission form on the Clinical Research Page to apply for research grants.

Thank you for your interest!

Unfortunately, we cannot take job applications or career inquiries through this web form due to GDPR regulations. Please apply through our Careers Page. Thank you for your interest!

Campbell Rogers, M.D., F.A.C.C.

Executive Vice President and Chief Medical Officer

Campbell brings a wealth of experience to HeartFlow, where he serves as the Chief Medical Officer. Prior to joining HeartFlow, he was the Chief Scientific Officer and Global Head of Research and Development at Cordis Corporation, Johnson & Johnson, where he was responsible for leading investments and research in cardiovascular devices. Prior to Cordis, he was Associate Professor of Medicine at Harvard Medical School and the Harvard-M.I.T. Division of Health Sciences and Technology, and Director of the Cardiac Catheterization and Experimental Cardiovascular Interventional Laboratories at Brigham and Women’s Hospital. He served as Principal Investigator for numerous interventional cardiology device, diagnostic, and pharmacology trials, is the author of numerous journal articles, chapters, and books in the area of coronary artery and other cardiovascular diseases, and was the recipient of research grant awards from the NIH and AHA.

He received his A.B. from Harvard College and his M.D. from Harvard Medical School.

本情報は日本国内の医療関係者を対象とした情報提供サイトです。
一般の方に対する情報提供を目的としたものではございません。
あなたは医療関係者ですか?